Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue 4
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
This article has a correction. Please see:
Correction: High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC - June 01, 2022
PDF
PDF +
Supplementary
Material
Immunotherapy biomarkers
Original research
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
Online download statistics by month:
Online download statistics by month: April 2022 to May 2022
Abstract
Full
Pdf
Apr 2022
335
356
108
May 2022
827
869
295
Total
1162
1225
403
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF